Botanical species · safety record

Geum urbanum

The EFSA Compendium of Botanicals holds 7 constituent measurements for Geum urbanum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Geum urbanum L.

7Constituent measurements
0Safety records
6Cited sources
48Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 48 licensed products naming Geum urbanum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA

Source material stated

  • Aerial parts
  • Dried grass
  • Herb top
  • Herb top and root
  • Leaf and flower
  • Leaves and flowers
  • Root
  • Whole plant

What the records describe

Constituents measured

  • Eugenol2
  • Gallic acid2
  • Ellagitannins (hydrolysable tannins)1
  • Gallotannins1
  • Tannins1

Plant parts

  • Roots and other underground parts4
  • Live plants2
  • Leaves1

Preparations

  • Solvent extraction6
  • Essential oil1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
EugenolRoots and other underground partsSolvent extractionGC-MSResolve DOI
EugenolRoots and other underground partsEssential oil67.1 PercentGC-MSResolve DOI
Gallic acidLive plantsSolvent extraction≤ 8.35 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Gallic acidLive plantsSolvent extraction≥ 5.25 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Ellagitannins (hydrolysable tannins)Roots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
GallotanninsRoots and other underground partsSolvent extractionChromatographic testsNo resolvable identifier
TanninsLeavesSolvent extraction12 PercentUnspecifiedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Owczarek, Aleksandra., Olszewska, Monika Anna., Gudej, Jan. QUANTITATIVE DETERMINATION OF ELLAGIC ACID AND GALLIC ACID IN GEUM RIVALE L. AND G. URBANUM L.. ACTA BIOLOGICA CRACOVIENSIA SERIES BOTANICA, 2014, vol. 56, no. 2, p. 74-78. DOI
  2. Rusu, Mihai Lucian., Marutoiu, Constantin., Sandu, Ion., Tita, Dumitru., Gogoasa, Ioan., Barbu, Constantin-Horia., Popescu, Andreea. HPTLC and GC-MS for separation and identification of eugenol in plants. Jpc-journal of planar chromatography-modern tlc, 2007, vol. 20, no. 2, p. 139-140. DOI
  3. Vollmann, C., Schultze, W. Composition of the Root Essential Oils of Several Geum Species and Related Members of the Subtribus Geinae (Rosaceae). FLAVOUR AND FRAGRANCE JOURNAL, 1995, vol. 10, no. 3, p. 173-178. DOI
  4. Granica, S., Piwowarski, J., Kiss, A. Isolation of tannins from Agrimonia eupatoria, Lythrum salicaria and Geum urbanum and their influence on the release of elastase from stimulated human neutrophils - structure-activity studies . Planta medica, 2014, vol. 80, no. 16, p. 1419-1419.
  5. Palade, Madelena., Teodorescu, Carmen., Heisu, Roxana. Phytochemical studies on the revaluation of the leaves of Geum urbanum L. Farmacia (bucharest, romania), 2001, p. 67-70.
  6. Gstirner, F., Widenmann, H. Contents of the rhizome of Geum urbanum. Scientia pharmaceutica, 1964, p. 98-104.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue